Pituitary & hypothalamus

Acromegaly increases depressive symptoms and reduces quality of life of cohabitants

PituitaryPublished Cross-sectional study

Authors' conclusion

The chronic process of acromegaly and the external appearance of patients with this disease can negatively affect both the patients and the people living with them. Physicians being aware of this effect and taking counteractive measures may contribute positively to the course of acromegaly.

Study context

Population
Patients with acromegaly and their cohabitants84 patients · 84 cohabitants
Exposure
Cohabitants affected vs not affected by the acromegalic appearance
Outcome
Cohabitants' anxiety (BAI), depression (BDI), caregiver burden (ZBI) and quality of life (QoL) (SF-36) by effect of acromegalic appearance

Main finding

As reported in the abstract

  • Affected vs Not affected: P < 0.001 for all
  • Affected vs Not affected: P = 0.015

Observational data: associations, not effects.

Further findings

Patients with acromegalic appearance

Patients with acromegalic appearance
69 (n = 84, 82.1%)

Correlation of cohabitants' scores with patients' AcroQoL

Beck Anxiety Inventory (BAI) vs AcroQoL
r=−0.535, p < 0.001
Beck Depression Inventory (BDI) vs AcroQoL
r=−0.592, p < 0.001
ZBI vs AcroQoL
r=−0.465, p < 0.001
SF-36 vs AcroQoL
r = 0.387, p < 0.001

Original publication

Acromegaly increases depressive symptoms and reduces quality of life of cohabitants. Pituitary. Published 30 December 2023. doi:10.1007/s11102-023-01376-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.